查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
载体筛查市场规模、份额和趋势分析报告：按类型（扩展载体筛查、靶向疾病载体筛查）、条件、技术、地区、细分市场预测，2023-2030 年
市场调查报告书
商品编码
1178643

载体筛查市场规模、份额和趋势分析报告：按类型（扩展载体筛查、靶向疾病载体筛查）、条件、技术、地区、细分市场预测，2023-2030 年

Carrier Screening Market Size, Share & Trends Analysis Report By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), By Medical Condition, By Technology, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

职业筛选市场的增长和趋势

根据Grandview Research的最新报告，到2030年，全球职业筛选市场规模预计将达到28.6亿美元，2023年至2030年的复合年增长率为12.4%。载体筛选技术的不断进步以及新兴市场体外受精采用率的提高预计将在预测期内推动市场增长。携带者从父母那里获得异常基因。镰状细胞性贫血、囊性纤维化、泰-萨克斯病、脆性 X 综合征和 SMA 等疾病可以通过携带者筛查来识别。

进行分子测试以通过寻找 DNA 中的异常来检测突变。使用下一代测序仪进行测试就是其中之一。携带者可能没有表现出任何疾病症状或体征。建议孕妇进行此测试，以查看胎儿是否可能存在遗传畸形。还鼓励孩子的男性父母参加职业筛选测试。此类遗传畸形的早期诊断和抑制因素有望促进市场增长。该测试使用面颊组织细胞、血液或唾液样本。

此外，精准医学市场正在采用载体筛选。2022 年 11 月发表在《The Medical Journal of Australia》上的一篇文章指出，基因组医学的快速创新以及基因密码测序技术为基因携带者筛查创造了有利可图的机会。为了将人口筛查整合到精准医学中，可以使用 RE-AIM 等框架来设计调查、评估障碍和评估结果。美国采用该策略来评估人群 DNA 筛查。

医院和监管机构为提高职业筛选的可及性而增加的战略举措预计将支持市场增长。例如，2022 年 6 月，NHS 宣布将 BRCA 基因检测扩展到犹太社区。据报导，每 40 个犹太人中就有一个是 BRCA 的携带者，这会增加患某些癌症的机率。同样，2022 年 6 月，UnitedHealthcare Community 提议在美国引入德系犹太人职业筛选的覆盖计划。

另一方面，在新兴市场，有限的公共卫生筛查实践、生殖健康和初级保健方面缺乏基因组知识以及基因组检测的成本预计将阻碍市场增长。在印度，携带者基因筛查的费用从 218 美元到 290 美元不等。考虑到该地区的平均购买力，对大多数人来说成本很高。

职业筛选市场报告亮点

按类型划分，不断扩大的职业筛选部分预计将在预测期内实现最快的增长率。现有参与者正在积极开发产品，以扩大筛选在精准医学和体外受精等各个领域的应用。

根据医疗条件，囊性纤维化部分预计将在 2022 年占据重要的市场份额并呈现显着增长。归因于疾病发病率和携带者频率的增加。玩家的产品开发可能会支持该细分市场的增长。

从技术上看，DNA 测序领域预计将在 2023 年至 2030 年以最快的复合年增长率增长。采用 NGS 技术进行产前诊断被认为是一个主要驱动因素。

按最终用途划分，实验室部分预计将在 2022 年占据大部分市场份额。这是由于发达国家拥有设备齐全的设施，而新兴市场农村地区的检测也在不断增加。

北美以 40.19% 的总市场份额巩固了其区域地位。这是由于该地区医院和参考实验室的存在以及主要企业的存在。

目录

第一章研究方法论

  • 各国市场：基本估计
  • 全球市场：复合年增长率计算
  • 按地区计算细分市场份额
  • 调查范围和假设
  • 数据源列表
    • 来自主要采访的数据来源
    • 按地区划分的首次采访数据

第二章执行摘要

  • 市场快照

3. 职业筛选市场变量、趋势和范围

  • 市场细分和范围
  • 市场驱动力分析
    • 越来越多地采用体外受精和冷冻保存
    • 筛选技术的技术进步
    • 新兴市场的意识不断增强
  • 市场约束因素分析
    • 公共卫生筛查的实施有限
  • 职业筛选 - SWOT 分析，按因素（政治与法律，经济与技术）
  • 行业分析 - 搬运工
  • 职业筛选市场：2022 年市场状况分析
  • COVID-19 影响分析

第四章职业筛选市场：类型估计和趋势分析

  • 职业筛选市场：类型差异分析
  • 扩大职业筛选
    • 扩大职业筛选市场
  • 靶向疾病携带者筛查
    • 目标疾病携带者筛查市场

5 职业筛查市场：医疗条件的估计和趋势分析

  • 职业筛选市场：医疗条件变化分析
  • 囊性纤维化
    • 囊性纤维化市场
  • 泰-萨克斯病
    • 泰萨克斯病市场
  • 戈谢病
    • 戈谢病市场
  • 镰状细胞性贫血症
    • 镰状细胞病市场
  • 脊髓性肌萎缩症
    • 脊髓性肌萎缩症市场
  • 其他
    • 其他市场

第 6 章职业筛选市场：技术估计和趋势分析

  • 职业筛选市场：技术波动分析
  • DNA测序
    • DNA测序市场
  • 聚合□链反应
    • 聚合□链反应市场
  • 微阵列
    • 芯片市场
  • 其他
    • 其他市场

第 7 章职业筛选市场：最终用户估计和趋势分析

  • 职业筛选市场：最终用户差异分析
  • 医院
    • 医院市场
  • 研究所
    • 实验室市场
  • 诊所和诊所
    • 诊所/诊所市场
  • 其他
    • 其他市场

8 职业筛选市场：按地区、类型、医疗条件、技术、最终用途的估计和趋势分析

  • 2022 年和 2030 年各地区职业筛选市场份额
  • 北美
    • SWOT分析
      • 按类型划分的北美职业筛选市场
      • 按医疗条件划分的北美职业筛选市场
      • 按技术划分的北美职业筛选市场
      • 北美载体筛选市场，按最终用途分类
    • 美国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的美国职业筛选市场
      • 美国职业筛选市场，按医疗条件
      • 按技术划分的美国职业筛选市场
      • 美国运营商筛选市场，按最终用途
    • 加拿大
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的加拿大职业筛选市场
      • 按医疗条件划分的加拿大职业筛选市场
      • 按技术划分的加拿大职业筛选市场
      • 加拿大运营商筛选市场，按最终用途分类
  • 欧洲
    • SWOT分析
      • 按类型划分的欧洲职业筛选市场
      • 欧洲职业筛选市场，按医疗条件
      • 欧洲职业筛选市场，按技术分类
      • 欧洲运营商筛选市场，按最终用途
    • 德国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 德国职业筛选市场类型
      • 德国职业筛选市场，按医疗条件
      • 德国职业筛选市场，按技术分类
      • 德国载体筛选市场，按最终用途分类
    • 英国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的英国职业筛选市场
      • 按医疗条件划分的英国职业筛选市场
      • 按技术划分的英国职业筛选市场
      • 英国职业筛选市场，按最终用途分类
    • 法国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的法国职业筛选市场
      • 法国职业筛选市场，按医疗条件
      • 法国职业筛选市场，按技术分类
      • 法国运营商筛选市场，按最终用途分类
    • 意大利
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的意大利职业筛选市场
      • 意大利职业筛选市场，按医疗条件
      • 意大利职业筛选市场，按技术分类
      • 意大利载体筛选市场，按最终用途分类
    • 西班牙
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 西班牙职业筛选市场按类型
      • 西班牙职业筛选市场，按医疗条件
      • 西班牙按技术划分的职业筛选市场
      • 西班牙职业筛选市场，按最终用途分类
    • 丹麦
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的丹麦职业筛选市场
      • 按医疗条件划分的丹麦职业筛选市场
      • 按技术划分的丹麦职业筛选市场
      • 丹麦载体筛选市场，按最终用途分类
    • 瑞典
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的瑞典职业筛选市场
      • 按医疗条件划分的瑞典职业筛选市场
      • 按技术划分的瑞典职业筛选市场
      • 瑞典运营商筛选市场，按最终用途分类
    • 挪威
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的挪威职业筛选市场
      • 按医疗条件划分的挪威职业筛选市场
      • 按技术划分的挪威职业筛选市场
      • 挪威职业筛选市场，按最终用途分类
  • 亚太地区
    • SWOT分析
      • 按类型分列的亚太职业筛选市场
      • 亚太地区职业筛选市场，按医疗条件
      • 按技术划分的亚太职业筛选市场
      • 亚太地区运营商筛选市场，按最终用途
    • 日本
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 日本按类型划分的职业筛选市场
      • 日本职业筛选市场，按医疗条件
      • 日本职业筛选市场，按技术分类
      • 日本载体筛选市场，按最终用途分类
    • 中国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的中国职业筛选市场
      • 中国职业筛选市场，按医疗条件
      • 按技术划分的中国职业筛选市场
      • 中国载体筛选市场，按最终用途分类
    • 印度
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的印度职业筛选市场
      • 印度职业筛选市场，按医疗条件
      • 印度职业筛选市场，按技术分类
      • 印度运营商筛选市场，按最终用途分类
    • 韩国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型分列的韩国职业筛选市场
      • 韩国职业筛选市场，按医疗条件
      • 按技术分类的韩国职业筛选市场
      • 韩国运营商筛选市场，按最终用途分类
    • 澳大利亚
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的澳大利亚职业筛选市场
      • 澳大利亚职业筛选市场，按医疗条件
      • 澳大利亚职业筛选市场，按技术分类
      • 澳大利亚运营商筛选市场，按最终用途
    • 泰国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型分列的泰国职业筛选市场
      • 泰国职业筛选市场，按医疗条件
      • 泰国职业筛选市场，按技术分类
      • 泰国载体筛选市场，按最终用途分类
  • 拉丁美洲
    • SWOT分析
      • 按类型划分的拉丁美洲职业筛选市场
      • 拉丁美洲职业筛选市场，按医疗条件
      • 拉丁美洲职业筛选市场，按技术分类
      • 拉丁美洲运营商筛选市场，按最终用途分类
    • 巴西
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的巴西职业筛选市场
      • 按医疗状况分列的巴西承运人筛查市场
      • 按技术分类的巴西职业筛选市场
      • 巴西载体筛选市场，按最终用途分类
    • 墨西哥
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的墨西哥职业筛选市场
      • 墨西哥职业筛选市场，按医疗条件
      • 按技术划分的墨西哥职业筛选市场
      • 墨西哥运营商筛选市场，按最终用途分类
    • 阿根廷
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的阿根廷职业筛选市场
      • 阿根廷职业筛选市场，按医疗条件
      • 按技术划分的阿根廷职业筛选市场
      • 阿根廷职业筛选市场，按最终用途分类
  • 多边环境协定
    • SWOT分析
      • 按类型划分的 MEA 职业筛选市场
      • MEA 职业筛选市场，按医疗条件
      • 按技术划分的 MEA 职业筛选市场
      • MEA 载体筛选市场，按最终用途分类
    • 南非
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的阿根廷职业筛选市场
      • 阿根廷职业筛选市场，按医疗条件
      • 按技术划分的阿根廷职业筛选市场
      • 阿根廷职业筛选市场，按最终用途分类
    • 沙特阿拉伯
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型分列的沙特阿拉伯职业筛选市场
      • 按医疗条件划分的沙特阿拉伯职业筛选市场
      • 按技术分类的沙特阿拉伯职业筛选市场
      • 沙特阿拉伯职业筛选市场，按最终用途分类
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型划分的阿拉伯联合酋长国职业筛选市场
      • 阿联酋职业筛选市场，按医疗条件
      • 阿联酋职业筛选市场，按技术分类
      • 阿联酋职业筛选市场，按最终用途分类
    • 科威特
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 按类型分列的科威特职业筛选市场
      • 科威特职业筛选市场，按医疗条件
      • 按技术划分的科威特职业筛选市场
      • 科威特职业筛选市场，按最终用途分类

第九章竞争格局

  • 市场进入者概览
  • 财务绩效
  • 市场进入者分类
    • 市场领导者
      • 2022 年职业筛选市场份额分析
      • 公司简介
      • Thermo Fisher Scientific Inc.
      • Myriad Genetics, Inc.
      • Cepheid
      • Laboratory Corporation of America Holdings
      • Otogenetics
      • Illumina Inc.
      • MedGenome
      • GeneTech
      • Centogene N.V.
      • F. Hoffman-La Roche Limited
    • 战略规划
      • 扩张
      • 获得
      • 合作
      • 产品/服务发布
      • 合伙
      • 其他
Product Code: GVR-4-68040-016-9

Carrier Screening Market Growth & Trends:

The global carrier screening market size is expected to reach USD 2.86 billion by 2030 and expand at a CAGR of 12.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increase in technological advancement in carrier screening along with the rising adoption of in vitro fertilization in emerging markets is expected to boost the market growth during the forecast period. The carrier receives the abnormal gene from the parents. Disorders such as sickle cell anemia, cystic fibrosis, Tay-Sachs disease, fragile X syndrome, and SMA can be identified using carrier screening.

Molecular tests are performed to detect the mutation by finding the abnormalities in the DNA. Next-generation sequencing is one of the techniques to perform tests. There is the possibility of the carrier not showing any symptoms and signs of illness. The test is recommended for pregnant women to check whether the baby will have a chance of genetic deformities. It is also advised to the male parent of the child to undergo the carrier screening test. The early-stage disease diagnosis and restraint of these genetic deformities is expected to augment the market growth. The test involves the tissue cells of the cheeks, blood, or saliva samples.

The adoption of carrier screening in the precision medicine market is also increasing. According to the article published in November 2022, by The Medical Journal of Australia, stated that the rapid innovations in genomic medicine along with sequencing technology for genetic code created a lucrative opportunity for genetic carrier screening. For incorporating population screening into precision medicine, a framework such as RE-AIM can be employed to plan research, assess barriers, and evaluates the result. This strategy was employed to assess the population DNA screening in the U.S.

The growing strategic initiatives by hospitals and regulatory bodies to increase the accessibility of carrier screening are expected to support market growth. For instance, in June 2022, NHS announced the expansion of BRCA genetic testing for the Jewish community. Since, 1 in 40 Jews is reported to be the carrier of BRCA, which increases the probability of certain cancers. Similarly, in June 2022, UnitedHealthcare Community proposed to introduce a coverage program for Ashkenazi Jewish Carrier Screening in the U.S.

On the other hand, limited implementation of public health screening, lack of genomic knowledge for reproductive health and primary care, and cost of genomic tests in the emerging market are expected to hamper the market growth. In India, the cost of carrier genetic screening ranges from USD 218 to USD 290. Considering the average purchasing power in the region, the cost is high for the majority of the population.

Carrier Screening Market Report Highlights:

  • By type, the expanded carrier screening segment is projected to establish the fastest growth rate over the forecast period. Since increasing product development by the existing players to expand the usage of screening in various fields, such as precision medicine and IVF.
  • By medical condition, the Cystic fibrosis segment is anticipated to have a significant growth rate with a considerable market share in 2022. Owing to the increase in the disease incidence rate and carrier frequency. The product development by the players is likely to support the growth of the segment.
  • By technology, the DNA sequencing segment is anticipated to have the fastest-growing CAGR between 2023 and 2030. The adoption of NGS technology for prenatal diagnostics is considered to be the key driver.
  • By end-user, the laboratory segment is projected to have a majority of the market share in 2022. This is attributed to the presence of well-equipped facilities in developed countries, along with the increasing tests in the rural areas of emerging markets.
  • North America has strengthened its regional position in the market with 40.19% of the overall market share. This is attributed to the presence of hospitals and reference labs, along with the existence of key players in the region.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Country Wise Market: Base Estimates
  • 1.2 Global Market: CAGR Calculation
  • 1.3 Region-Based Segment Share Calculation
  • 1.4 Research Scope & Assumptions
  • 1.5 List of Data Sources
    • 1.5.1 Data for primary interviews, by sources
    • 1.5.2 Data for primary interviews, by region

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Carrier Screening Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Driver Analysis
    • 3.2.1 Increasing adoption of IVF and cryopreservation
    • 3.2.2 Technology advancement in screening techniques
    • 3.2.3 Rising awareness in the emerging market
  • 3.3 Market Restraint Analysis
    • 3.3.1 Limited implementation of public health screening
  • 3.4 Carrier screening - SWOT Analysis, By Factor (political & legal, economic, and technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Carrier Screening Market: Market Position Analysis, 2022
  • 3.7 COVID-19 Impact Analysis

Chapter 4 Carrier Screening Market: Type Estimates & Trend Analysis

  • 4.1 Carrier screening Market: Type Movement Analysis
  • 4.2 Expanded carrier screening
    • 4.2.1 Expanded carrier screening market
  • 4.3 Targeted disease carrier screening
    • 4.3.1 Targeted disease carrier screening market

Chapter 5 Carrier Screening Market: Medical Conditions Estimates & Trend Analysis

  • 5.1 Carrier Screening Market: Medical Conditions Movement Analysis
  • 5.2 Cystic fibrosis
    • 5.2.1 Cystic fibrosis market
  • 5.3 Tay-Sachs
    • 5.3.1 Tay-Sachs market
  • 5.4 Gaucher disease
    • 5.4.1 Gaucher disease market
  • 5.5 Sickle cell disease
    • 5.5.1 Sickle cell disease market
  • 5.6 Spinal muscular atrophy
    • 5.6.1 Spinal muscular atrophy market
  • 5.7 Other
    • 5.7.1 Other market

Chapter 6 Carrier screening Market: Technology Estimates & Trend Analysis

  • 6.1 Carrier screening Market: Technology Movement Analysis
  • 6.2 DNA sequencing
    • 6.2.1 DNA sequencing market
  • 6.3 Polymerase chain reaction
    • 6.3.1 Polymerase chain reaction market
  • 6.4 Microarrays
    • 6.4.1 Microarrays market
  • 6.5 Other
    • 6.5.1 Other market

Chapter 7 Carrier screening Market: End-user Estimates & Trend Analysis

  • 7.1 Carrier screening Market: End-user Movement Analysis
  • 7.2 Hospitals
    • 7.2.1 Hospitals market
  • 7.3 Laboratories
    • 7.3.1 Laboratories market
  • 7.4 Physician offices & clinics
    • 7.4.1 Physician offices & clinics market
  • 7.5 Other
    • 7.5.1 Other market

Chapter 8 Carrier screening Market: Regional Estimates & Trend Analysis, by Type, Medical Condition, Technology, End-user

  • 8.1 Carrier Screening Market Share By Region, 2022 & 2030
  • 8.2 North America
    • 8.2.1 SWOT Analysis
      • 8.2.1.1 North America carrier screening market, by type
      • 8.2.1.2 North America carrier screening market, by medical condition
      • 8.2.1.3 North America carrier screening market, by technology
      • 8.2.1.4 North America carrier screening market, by end-user
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 Target Disease Prevalence
      • 8.2.2.3 Competitive Scenario
      • 8.2.2.4 Regulatory Framework
      • 8.2.2.5 Reimbursement Scenario
      • 8.2.2.6 U.S. carrier screening market, by type
      • 8.2.2.7 U.S. carrier screening market, by medical condition
      • 8.2.2.8 U.S. carrier screening market, by technology
      • 8.2.2.9 U.S. carrier screening market, by end-user
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Target Disease Prevalence
      • 8.2.3.3 Competitive Scenario
      • 8.2.3.4 Regulatory Framework
      • 8.2.3.5 Reimbursement Scenario
      • 8.2.3.6 Canada carrier screening market, by type
      • 8.2.3.7 Canada carrier screening market, by medical condition
      • 8.2.3.8 Canada carrier screening market, by technology
      • 8.2.3.9 Canada carrier screening market, by end-user
  • 8.3 Europe
    • 8.3.1 SWOT Analysis
      • 8.3.1.1 Europe carrier screening market, by type
      • 8.3.1.2 Europe carrier screening market, by medical condition
      • 8.3.1.3 Europe carrier screening market, by technology
      • 8.3.1.4 Europe carrier screening market, by end-user
    • 8.3.2 Germany
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 Target Disease Prevalence
      • 8.3.2.3 Competitive Scenario
      • 8.3.2.4 Regulatory Framework
      • 8.3.2.5 Reimbursement Scenario
      • 8.3.2.6 Germany carrier screening market, by type
      • 8.3.2.7 Germany carrier screening market, by medical condition
      • 8.3.2.8 Germany carrier screening market, by technology
      • 8.3.2.9 Germany carrier screening market, by end-user
    • 8.3.3 U.K.
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Target Disease Prevalence
      • 8.3.3.3 Competitive Scenario
      • 8.3.3.4 Regulatory Framework
      • 8.3.3.5 Reimbursement Scenario
      • 8.3.3.6 U.K. carrier screening market, by type
      • 8.3.3.7 U.K. carrier screening market, by medical condition
      • 8.3.3.8 U.K. carrier screening market, by technology
      • 8.3.3.9 U.K. carrier screening market, by end-user
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 Target Disease Prevalence
      • 8.3.4.3 Competitive Scenario
      • 8.3.4.4 Regulatory Framework
      • 8.3.4.5 Reimbursement Scenario
      • 8.3.4.6 France carrier screening market, by type
      • 8.3.4.7 France carrier screening market, by medical condition
      • 8.3.4.8 France carrier screening market, by technology
      • 8.3.4.9 France carrier screening market, by end-user
    • 8.3.5 Italy
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Target Disease Prevalence
      • 8.3.5.3 Competitive Scenario
      • 8.3.5.4 Regulatory Framework
      • 8.3.5.5 Reimbursement Scenario
      • 8.3.5.6 Italy carrier screening market, by type
      • 8.3.5.7 Italy carrier screening market, by medical condition
      • 8.3.5.8 Italy carrier screening market, by technology
      • 8.3.5.9 Italy carrier screening market, by end-user
    • 8.3.6 Spain
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Target Disease Prevalence
      • 8.3.6.3 Competitive Scenario
      • 8.3.6.4 Regulatory Framework
      • 8.3.6.5 Reimbursement Scenario
      • 8.3.6.6 Spain carrier screening market, by type
      • 8.3.6.7 Spain carrier screening market, by medical condition
      • 8.3.6.8 Spain carrier screening market, by technology
      • 8.3.6.9 Spain carrier screening market, by end-user
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Target Disease Prevalence
      • 8.3.7.3 Competitive Scenario
      • 8.3.7.4 Regulatory Framework
      • 8.3.7.5 Reimbursement Scenario
      • 8.3.7.6 Denmark carrier screening market, by type
      • 8.3.7.7 Denmark carrier screening market, by medical condition
      • 8.3.7.8 Denmark carrier screening market, by technology
      • 8.3.7.9 Denmark carrier screening market, by end-user
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Target Disease Prevalence
      • 8.3.8.3 Competitive Scenario
      • 8.3.8.4 Regulatory Framework
      • 8.3.8.5 Reimbursement Scenario
      • 8.3.8.6 Sweden carrier screening market, by type
      • 8.3.8.7 Sweden carrier screening market, by medical condition
      • 8.3.8.8 Sweden carrier screening market, by technology
      • 8.3.8.9 Sweden carrier screening market, by end-user
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Target Disease Prevalence
      • 8.3.9.3 Competitive Scenario
      • 8.3.9.4 Regulatory Framework
      • 8.3.9.5 Reimbursement Scenario
      • 8.3.9.6 Norway carrier screening market, by type
      • 8.3.9.7 Norway carrier screening market, by medical condition
      • 8.3.9.8 Norway carrier screening market, by technology
      • 8.3.9.9 Norway carrier screening market, by end-user
  • 8.4 Asia Pacific
    • 8.4.1 SWOT Analysis
      • 8.4.1.1 Asia Pacific carrier screening market, by type
      • 8.4.1.2 Asia Pacific carrier screening market, by medical condition
      • 8.4.1.3 Asia Pacific carrier screening market, by technology
      • 8.4.1.4 Asia Pacific carrier screening market, by end-user
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Target Disease Prevalence
      • 8.4.2.3 Competitive Scenario
      • 8.4.2.4 Regulatory Framework
      • 8.4.2.5 Reimbursement Scenario
      • 8.4.2.6 Japan carrier screening market, by type
      • 8.4.2.7 Japan carrier screening market, by medical condition
      • 8.4.2.8 Japan carrier screening market, by technology
      • 8.4.2.9 Japan carrier screening market, by end-user
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 Target Disease Prevalence
      • 8.4.3.3 Competitive Scenario
      • 8.4.3.4 Regulatory Framework
      • 8.4.3.5 Reimbursement Scenario
      • 8.4.3.6 China carrier screening market, by type
      • 8.4.3.7 China carrier screening market, by medical condition
      • 8.4.3.8 China carrier screening market, by technology
      • 8.4.3.9 China carrier screening market, by end-user
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 Target Disease Prevalence
      • 8.4.4.3 Competitive Scenario
      • 8.4.4.4 Regulatory Framework
      • 8.4.4.5 Reimbursement Scenario
      • 8.4.4.6 India carrier screening market, by type
      • 8.4.4.7 India carrier screening market, by medical condition
      • 8.4.4.8 India carrier screening market, by technology
      • 8.4.4.9 India carrier screening market, by end-user
    • 8.4.5 South Korea
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Target Disease Prevalence
      • 8.4.5.3 Competitive Scenario
      • 8.4.5.4 Regulatory Framework
      • 8.4.5.5 Reimbursement Scenario
      • 8.4.5.6 South Korea carrier screening market, by type
      • 8.4.5.7 South Korea carrier screening market, by medical condition
      • 8.4.5.8 South Korea carrier screening market, by technology
      • 8.4.5.9 South Korea carrier screening market, by end-user
    • 8.4.6 Australia
      • 8.3.9.1 Key Country Dynamics
      • 8.4.6.2 Target Disease Prevalence
      • 8.4.6.3 Competitive Scenario
      • 8.4.6.4 Regulatory Framework
      • 8.4.6.5 Reimbursement Scenario
      • 8.4.6.6 Australia carrier screening market, by type
      • 8.4.6.7 Australia carrier screening market, by medical condition
      • 8.4.6.8 Australia carrier screening market, by technology
      • 8.4.6.9 Australia carrier screening market, by end-user
    • 8.4.7 Thailand
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 Target Disease Prevalence
      • 8.4.7.3 Competitive Scenario
      • 8.4.7.4 Regulatory Framework
      • 8.4.7.5 Reimbursement Scenario
      • 8.4.7.6 Thailand carrier screening market, by type
      • 8.4.7.7 Thailand carrier screening market, by medical condition
      • 8.4.7.8 Thailand carrier screening market, by technology
      • 8.4.7.9 Thailand carrier screening market, by end-user
  • 8.5 Latin America
    • 8.5.1 SWOT Analysis
      • 8.5.1.1 Latin America carrier screening market, by type
      • 8.5.1.2 Latin America carrier screening market, by medical condition
      • 8.5.1.3 Latin America carrier screening market, by technology
      • 8.5.1.4 Latin America carrier screening market, by end-user
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Target Disease Prevalence
      • 8.5.2.3 Competitive Scenario
      • 8.5.2.4 Regulatory Framework
      • 8.5.2.5 Reimbursement Scenario
      • 8.5.2.6 Brazil carrier screening market, by type
      • 8.5.2.7 Brazil carrier screening market, by medical condition
      • 8.5.2.8 Brazil carrier screening market, by technology
      • 8.5.2.9 Brazil carrier screening market, by end-user
    • 8.5.3 Mexico
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Target Disease Prevalence
      • 8.5.3.3 Competitive Scenario
      • 8.5.3.4 Regulatory Framework
      • 8.5.3.5 Reimbursement Scenario
      • 8.5.3.6 Mexico carrier screening market, by type
      • 8.5.3.7 Mexico carrier screening market, by medical condition
      • 8.5.3.8 Mexico carrier screening market, by technology
      • 8.5.3.9 Mexico carrier screening market, by end-user
    • 8.5.4 Argentina
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Target Disease Prevalence
      • 8.5.4.3 Competitive Scenario
      • 8.5.4.4 Regulatory Framework
      • 8.5.4.5 Reimbursement Scenario
      • 8.5.4.6 Argentina carrier screening market, by type
      • 8.5.4.7 Argentina carrier screening market, by medical condition
      • 8.5.4.8 Argentina carrier screening market, by technology
      • 8.5.4.9 Argentina carrier screening market, by end-user
  • 8.6 MEA
    • 8.6.1 SWOT Analysis
      • 8.6.1.1 MEA carrier screening market, by type
      • 8.6.1.2 MEA carrier screening market, by medical condition
      • 8.6.1.3 MEA carrier screening market, by technology
      • 8.6.1.4 MEA carrier screening market, by end-user
    • 8.6.2 South Africa
      • 8.6.4.1 Key Country Dynamics
      • 8.6.2.2 Target Disease Prevalence
      • 8.6.2.3 Competitive Scenario
      • 8.6.2.4 Regulatory Framework
      • 8.6.2.5 Reimbursement Scenario
      • 8.6.2.6 Argentina carrier screening market, by type
      • 8.6.2.7 Argentina carrier screening market, by medical condition
      • 8.6.2.8 Argentina carrier screening market, by technology
      • 8.6.2.9 Argentina carrier screening market, by end-user
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Target Disease Prevalence
      • 8.6.3.3 Competitive Scenario
      • 8.6.3.4 Regulatory Framework
      • 8.6.3.5 Reimbursement Scenario
      • 8.6.3.6 Saudi Arabia carrier screening market, by type
      • 8.6.3.7 Saudi Arabia carrier screening market, by medical condition
      • 8.6.3.8 Saudi Arabia carrier screening market, by technology
      • 8.6.3.9 Saudi Arabia carrier screening market, by end-user
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 Target Disease Prevalence
      • 8.6.4.3 Competitive Scenario
      • 8.6.4.4 Regulatory Framework
      • 8.6.4.5 Reimbursement Scenario
      • 8.6.4.6 UAE carrier screening market, by type
      • 8.6.4.7 UAE carrier screening market, by medical condition
      • 8.6.4.8 UAE carrier screening market, by technology
      • 8.6.4.9 UAE carrier screening market, by end-user
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Target Disease Prevalence
      • 8.6.5.3 Competitive Scenario
      • 8.6.5.4 Regulatory Framework
      • 8.6.5.5 Reimbursement Scenario
      • 8.6.5.6 Kuwait carrier screening market, by type
      • 8.6.5.7 Kuwait carrier screening market, by medical condition
      • 8.6.5.8 Kuwait carrier screening market, by technology
      • 8.6.5.9 Kuwait carrier screening market, by end-user

Chapter 9 Competitive Landscape

  • 9.1 Participant's overview
  • 9.2 Financial performance
  • 9.3 Participant categorization
    • 9.3.1 Market leaders
      • 9.3.1.1 Carrier screening market share analysis, 2022
      • 9.3.1.2 Company profiles
      • 9.3.1.2.1 Thermo Fisher Scientific Inc.
      • 9.3.1.2.2 Myriad Genetics, Inc.
      • 9.3.1.2.3 Cepheid
      • 9.3.1.2.4 Laboratory Corporation of America Holdings
      • 9.3.1.2.5 Otogenetics
      • 9.3.1.2.6 Illumina Inc.
      • 9.3.1.2.7 MedGenome
      • 9.3.1.2.8 GeneTech
      • 9.3.1.2.9 Centogene N.V.
      • 9.3.1.2.10 F. Hoffman-La Roche Limited
    • 9.3.2 Strategy mapping
      • 9.3.2.1 Expansion
      • 9.3.2.2 Acquisition
      • 9.3.2.3 Collaborations
      • 9.3.2.4 Product/service launch
      • 9.3.2.5 Partnerships
      • 9.3.2.6 Others

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 5 Global Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 6 Global Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 7 Global Carrier screening Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Carrier screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 North America Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 11 North America Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 North America Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 13 U.S. Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 15 U.S. Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 17 Canada Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 19 Canada Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 20 Canada Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 21 Europe Carrier screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 24 Europe Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 Europe Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 26 Germany Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 28 Germany Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29 Germany Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 30 U.K. Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 U.K. Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 32 U.K. Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 33 U.K. Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 34 France Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 France Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 36 France Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 France Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 38 Italy Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 40 Italy Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Italy Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 42 Spain Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 44 Spain Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 45 Spain Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 46 Denmark Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Denmark Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 48 Denmark Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 49 Denmark Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 50 Sweden Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 52 Sweden Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Sweden Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 54 Norway Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 56 Norway Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Norway Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Carrier screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 63 China Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 China Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 65 China Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 China Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 67 Japan Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Japan Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 69 Japan Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 70 Japan Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 71 India Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 India Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 73 India Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 74 India Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 75 South Korea Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 77 South Korea Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 South Korea Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 79 Australia Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 Australia Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 81 Australia Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 Australia Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 83 Thailand Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 85 Thailand Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 Thailand Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 87 Latin America Carrier screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 90 Latin America Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 91 Latin America Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 92 Brazil Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 94 Brazil Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Brazil Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 96 Mexico Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 97 Mexico Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 98 Mexico Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 99 Mexico Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 100 Argentina Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 102 Argentina Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 103 Argentina Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Carrier screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 109 South Africa Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 110 South Africa Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 111 South Africa Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 112 South Africa Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 117 UAE Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 118 UAE Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 119 UAE Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 120 UAE Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Carrier screening Market, by End-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Carrier screening Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
  • Fig. 16 Global Carrier screening Market: Type Movement Analysis
  • Fig. 17 Global Carrier screening Market, for Expanded Carrier Screening, 2018 - 2030 (USD Million)
  • Fig. 18 Global Carrier screening Market, for Targeted Disease, 2018 - 2030 (USD Million)
  • Fig. 19 Global Carrier screening Market: Medical Condition Movement Analysis
  • Fig. 20 Global Carrier screening Market, for Cystic Fibrosis, 2018 - 2030 (USD Million)
  • Fig. 21 Global Carrier screening Market, for Tay-Sachs, 2018 - 2030 (USD Million)
  • Fig. 22 Global Carrier screening Market, for Gaucher Disease, 2018 - 2030 (USD Million)
  • Fig. 23 Global Carrier screening Market, for Sickle Cell Disease, 2018 - 2030 (USD Million)
  • Fig. 24 Global Carrier screening Market, for Spinal Muscular Atrophy, 2018 - 2030 (USD Million)
  • Fig. 25 Global Carrier screening Market, for Other, 2018 - 2030 (USD Million)
  • Fig. 26 Global Carrier screening Market: Technology Movement Analysis
  • Fig. 27 Global Carrier screening Market, for DNA Sequencing, 2018 - 2030 (USD Million)
  • Fig. 28 Global Carrier screening Market, for Polymerase Chain Reaction, 2018 - 2030 (USD Million)
  • Fig. 29 Global Carrier screening Market, for Microarrays, 2018 - 2030 (USD Million)
  • Fig. 30 Global Carrier screening Market, for Other, 2018 - 2030 (USD Million)
  • Fig. 31 Global Carrier screening Market: End User Movement Analysis
  • Fig. 32 Global Carrier screening Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 33 Global Carrier screening Market, for Laboratories, 2018 - 2030 (USD Million)
  • Fig. 34 Global Carrier screening Market, for Physician Offices & Clinics, 2018 - 2030 (USD Million)
  • Fig. 35 Global Carrier screening Market, for Other, 2018 - 2030 (USD Million)
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 Regional Outlook, 2022 & 2030
  • Fig. 38 Global Carrier screening Market: Region Movement Analysis
  • Fig. 39 North America Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 42 Europe Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 44 U.K. Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 45 France Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 46 Italy Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 53 China Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 54 India Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 55 Australia Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 62 Middle East and Africa Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait Carrier screening Market, 2018 - 2030 (USD Million)